Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes

Agarwal, RajivRossignol, PatrickMayo, Martha R.Conrad, AnsgarArthur, SusanWilliams, BryanWhite, William B.2023-08-282023-08-282021Agarwal R, Rossignol P, Mayo MR, et al. Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Clin J Am Soc Nephrol. 2021;16(9):1407-1409. doi:10.2215/CJN.02890221https://hdl.handle.net/1805/35171en-USPublisher PolicyChronic renal insufficiencyDiabetesHyperkalemiaHypertensionPatiromerPolymersResistant hypertensionSpironolactonePatiromer to Enable Spironolactone in Patients with Resistant Hypertension and CKD (AMBER): Results in the Prespecified Subgroup with DiabetesArticle